Investor KKR Group Partnership L.P.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by KKR Group Partnership L.P. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-03-10 13D/A GEL / Genesis Energy, L.P. - Limited Partnership 12,668,389 7,847,861
2025-03-07 13D/A 4,000,000
2024-02-26 13D/A 0
2024-01-25 13D/A 2,559,849
2024-01-05 13D/A TEDU / Tarena International, Inc. - Depositary Receipt (Common Stock) 5,971,523 5,263,858
2023-12-19 13D/A TEDU / Tarena International, Inc. - Depositary Receipt (Common Stock) 6,826,263 5,971,523
2023-02-13 13G/A EDR / Endeavor Group Holdings, Inc. 20,833,332 13,675,772
2023-02-13 13G/A KREF / KKR Real Estate Finance Trust Inc. 14,250,001 10,000,001
2022-02-10 13G/A KREF / KKR Real Estate Finance Trust Inc. 21,234,528 14,250,001
2021-12-01 13D/A TEDU / Tarena International, Inc. - Depositary Receipt (Common Stock) 6,826,263 6,826,263
2021-06-24 13D/A FOCS / Focus Financial Partners Inc - Class A 7,448,385 0
2021-05-13 13G EDR / Endeavor Group Holdings, Inc. 3,335,928 20,833,332
2021-05-03 13D/A TEDU / Tarena International, Inc. - Depositary Receipt (Common Stock) 6,826,263
2021-03-03 13D/A FOCS / Focus Financial Partners Inc - Class A 9,523,809 7,448,385
2021-02-12 13G/A NEP / XPLR Infrastructure, LP - Limited Partnership 3,399,212 0
2021-02-12 13G/A KREF / KKR Real Estate Finance Trust Inc. 22,008,616 21,234,528
2020-12-28 13D/A 4R5 / RigNet Inc 4,968,239 5,000,254
2020-02-14 13G/A KREF / KKR Real Estate Finance Trust Inc. 22,008,616 22,008,616
2020-02-14 13G/A SAIC / Science Applications International Corporation 4,032,201 2,863,701
2020-02-14 13G/A NEP / XPLR Infrastructure, LP - Limited Partnership 5,098,750 3,399,212
2019-12-02 13D/A CHRS / Coherus Oncology, Inc. 3,949,829 3,949,829
2019-11-29 13D/A CHRS / Coherus Oncology, Inc. 3,055,055 3,949,829
2019-07-15 13D GEL / Genesis Energy, L.P. - Limited Partnership 12,668,389
2019-04-30 13G NEP / XPLR Infrastructure, LP - Limited Partnership 5,098,750
2019-02-13 13G/A KREF / KKR Real Estate Finance Trust Inc. 23,758,616 22,008,616
2019-01-24 13G SAIC / Science Applications International Corporation 4,032,201
2019-01-16 13D/A EGL / Engility Holdings, Inc. 17,920,892 0
2018-09-27 13D/A HNGR / Hanger Inc 2,548,197 1,085,897
2018-09-17 13D/A HNGR / Hanger Inc 3,220,476 2,548,197
2018-09-11 13D/A EGL / Engility Holdings, Inc. 17,920,892 17,920,892
2018-08-30 13D/A 4R5 / RigNet Inc 4,968,239
2018-08-02 13D/A COOP / Mr. Cooper Group Inc. 71,465,629 187,344,571
2018-08-01 13D FOCS / Focus Financial Partners Inc - Class A 9,523,809
2018-04-06 13D/A EGL / Engility Holdings, Inc. 18,796,791 17,920,892
2018-03-13 13G/A WRD / WeRide Inc. - Depositary Receipt (Common Stock) 5,518,125 4,859,124
2018-02-15 13D/A COOP / Mr. Cooper Group Inc. 71,465,629 71,465,629
2018-02-13 13G KREF / KKR Real Estate Finance Trust Inc. 23,758,616
2018-02-05 13G WRD / WeRide Inc. - Depositary Receipt (Common Stock) 5,518,125
2018-01-09 13D/A COOP / Mr. Cooper Group Inc. 71,465,629
2017-12-11 13D/A ENTL / Entellus Medical, Inc. 1,405,372 1,405,372
2017-07-21 13D ENTL / Entellus Medical, Inc. 1,405,372
2016-03-11 13D HNGR / Hanger Inc 3,220,476
2015-12-31 13D/A WBA / Walgreens Boots Alliance, Inc. 52,461,215
2015-03-05 13D EGL / Engility Holdings, Inc. 18,796,791
2015-02-13 13G/A NXPI / NXP Semiconductors N.V. 0
2015-01-23 13D/A ABC / Amerisource Bergen Corp. 0
2015-01-07 13D COOP / Mr. Cooper Group Inc. 71,465,629
2014-12-31 13D WBA / Walgreens Boots Alliance, Inc. 146,088,689
2014-11-17 13D CHRS / Coherus Oncology, Inc. 3,055,055
2014-06-18 13D/A 3,335,928
2014-06-09 13D/A MRVL / Marvell Technology, Inc. 6,646,127
2014-04-09 13D/A 2,465,070
2014-02-14 13G/A NXPI / NXP Semiconductors N.V. 14,059,822
2013-12-30 13D MRVL / Marvell Technology, Inc. 33,641,300
2013-12-09 13D/A 1,926,148
2013-10-28 13D 1,417,166
2013-09-26 13D/A 4R5 / RigNet Inc 4,750,000
2013-09-23 13D 4R5 / RigNet Inc 4,750,000
2013-03-12 13D/A JAZZ / Jazz Pharmaceuticals plc 3,790,783
2013-02-14 13G/A NXPI / NXP Semiconductors N.V. 32,197,150
2012-03-14 13D/A JAZZ / Jazz Pharmaceuticals plc 7,540,783
2012-02-14 13G/A NXPI / NXP Semiconductors N.V. 40,028,656
2012-01-27 13D JAZZ / Jazz Pharmaceuticals plc 10,540,783